Perceptive Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,532
Closed -$499K 159
2017
Q2
$499K Buy
+8,532
New +$443K 0.03% 115
2017
Q1
Sell
-12,636
Closed -$665K 212
2016
Q4
$665K Hold
12,636
0.05% 105
2016
Q3
$563K Buy
+12,636
New +$548K 0.04% 113
2016
Q2
Sell
-11,846
Closed -$488K 208
2016
Q1
$488K Buy
+11,846
New +$488K 0.04% 131
2015
Q4
Sell
-7,261
Closed -$290K 179
2015
Q3
$290K Hold
7,261
0.02% 119
2015
Q2
$291K Buy
+7,261
New +$251K 0.02% 142

Other funds holding SYNH

Perceptive Advisors's SYNH Position: Q3 2017 in Review

Perceptive Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 8,532 shares — an estimated $499K sold.

Perceptive Advisors first reported a position in SYNH in Q2 2015 and held it in 6 quarters. The position peaked at $665K in Q4 2016. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • Perceptive Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
  • Perceptive Advisors sold 8,532 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $499K.
  • Perceptive Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 6 quarters.
  • Perceptive Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $665K in Q4 2016.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Perceptive Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.